Production (Stage)
VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -100.00% | 111.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -100.00% | 111.16% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -100.00% | 111.16% | |||
| SG&A Expenses | -15.23% | -11.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.60% | -10.68% | |||
| Operating Income | 14.20% | 13.38% | |||
| Income Before Tax | 10.98% | 11.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.48% | 11.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.48% | 11.57% | |||
| EBIT | 14.20% | 13.38% | |||
| EBITDA | 14.20% | 13.35% | |||
| EPS Basic | 18.97% | 12.12% | |||
| Normalized Basic EPS | 11.11% | 12.20% | |||
| EPS Diluted | 18.97% | 12.12% | |||
| Normalized Diluted EPS | 11.11% | 12.20% | |||
| Average Basic Shares Outstanding | 2.43% | 0.19% | |||
| Average Diluted Shares Outstanding | 2.43% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||